INOVIO PHARMACEUTICALS, INC. Increase (Decrease) in Restricted Cash
INOVIO PHARMACEUTICALS, INC. (INO) reported Increase (Decrease) in Restricted Cash of $0 for the 12-month period ending 2016-12-31, per its 10-K filed 2017-03-15.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInRestrictedCash · last filed 2017-03-15
- INOVIO PHARMACEUTICALS, INC. increase (decrease) in restricted cash for the quarter ending 2015-12-31 was $0.00.
- INOVIO PHARMACEUTICALS, INC. increase (decrease) in restricted cash for the quarter ending 2014-12-31 was $0.00, a 100.00% decline year-over-year.
- INOVIO PHARMACEUTICALS, INC. increase (decrease) in restricted cash for the quarter ending 2014-09-30 was -$100.93K, a 114793.18% decline year-over-year.
- INOVIO PHARMACEUTICALS, INC. increase (decrease) in restricted cash for the quarter ending 2014-06-30 was $81.00, a 8.99% decline year-over-year.
- INOVIO PHARMACEUTICALS, INC. increase (decrease) in restricted cash for fiscal 2016 was $0.00.
- INOVIO PHARMACEUTICALS, INC. increase (decrease) in restricted cash for fiscal 2015 was $0.00.
- INOVIO PHARMACEUTICALS, INC. increase (decrease) in restricted cash for fiscal 2014 was -$100.76K, a 28725.57% decline from fiscal 2013.
- INOVIO PHARMACEUTICALS, INC. increase (decrease) in restricted cash for fiscal 2013 was $352.00, a 0.28% increase from fiscal 2012.
| Period end | Increase (Decrease) in Restricted Cash 3 month | Increase (Decrease) in Restricted Cash 6 month | Increase (Decrease) in Restricted Cash 9 month | Increase (Decrease) in Restricted Cash 12 month | Increase (Decrease) in Restricted Cash 12 month as first filed |
|---|---|---|---|---|---|
| 2016-12-31 | $0.00 10-K · filed 2017-03-15 | ||||
| 2015-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-15 | $0.00 10-K · filed 2017-03-15 | |||
| 2015-09-30 | $0.00 10-Q · filed 2015-11-09 | ||||
| 2014-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-15 | -$100.93K derived: sum of 2 quarters · filed 2017-03-15 | -$100.85K derived: sum of 3 quarters · filed 2017-03-15 | -$100.76K 10-K · filed 2017-03-15 | |
| 2014-09-30 | -$100.93K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-09 | -$100.85K derived: sum of 2 quarters · filed 2015-11-09 | -$100.76K 10-Q · filed 2015-11-09 | -$100.67K derived: sum of 4 quarters · filed 2016-03-14 | |
| 2014-06-30 | $81.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-11 | $168.00 10-Q · filed 2014-08-11 | $256.00 derived: sum of 3 quarters · filed 2016-03-14 | $344.00 derived: sum of 4 quarters · filed 2016-03-14 | |
| 2014-03-31 | $87.00 10-Q · filed 2014-05-12 | $175.00 derived: sum of 2 quarters · filed 2016-03-14 | $263.00 derived: sum of 3 quarters · filed 2016-03-14 | $352.00 derived: sum of 4 quarters · filed 2016-03-14 | |
| 2013-12-31 | $88.00 derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-14 | $176.00 derived: sum of 2 quarters · filed 2016-03-14 | $265.00 derived: sum of 3 quarters · filed 2016-03-14 | $352.00 10-K · filed 2016-03-14 | |
| 2013-09-30 | $88.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-10 | $177.00 derived: sum of 2 quarters · filed 2014-11-10 | $264.00 10-Q · filed 2014-11-10 | $351.00 derived: sum of 4 quarters · filed 2015-03-16 | |
| 2013-06-30 | $89.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-11 | $176.00 10-Q · filed 2014-08-11 | $263.00 derived: sum of 3 quarters · filed 2015-03-16 | $352.00 derived: sum of 4 quarters · filed 2015-03-16 | |
| 2013-03-31 | $87.00 10-Q · filed 2014-05-12 | $174.00 derived: sum of 2 quarters · filed 2015-03-16 | $263.00 derived: sum of 3 quarters · filed 2015-03-16 | $351.00 derived: sum of 4 quarters · filed 2015-03-16 | |
| 2012-12-31 | $87.00 derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-16 | $176.00 derived: sum of 2 quarters · filed 2015-03-16 | $264.00 derived: sum of 3 quarters · filed 2015-03-16 | $351.00 10-K · filed 2015-03-16 | |
| 2012-09-30 | $89.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-12 | $177.00 derived: sum of 2 quarters · filed 2013-11-12 | $264.00 10-Q · filed 2013-11-12 | ||
| 2012-06-30 | $88.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-09 | $175.00 10-Q · filed 2013-08-09 | |||
| 2012-03-31 | $87.00 10-Q · filed 2013-05-10 | ||||
| 2011-12-31 | $100.06K 10-K · filed 2014-03-17 | -$100.06K 10-K · filed 2012-03-15 | |||
| 2010-12-31 | $0.00 10-K · filed 2013-03-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |
| Aardvark Therapeutics, Inc. (AARD) | United States | $0.121B | -1.80 |
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | United States | $0.121B | -8.95 |
| Coya Therapeutics, Inc. (COYA) | United States | $0.121B | -6.35 |
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| OnKure Therapeutics, Inc. (OKUR) | United States | $0.119B | -3.13 |
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| TuHURA Biosciences, Inc./NV (HURA) | United States | $0.134B | -4.88 |
| Immuneering Corp (IMRX) | United States | $0.113B | -12.51 |